IGC ~~~~~~~~ $0.65

IGC ~~~~~~~~ $0.65

IGC ~~~~~~~~ 0.6279


India Globalization Capital, Inc., through its subsidiaries, operates as an integrated infrastructure company in India and China. It engages in the execution of civil construction, structural engineering projects, and trading primarily in the Indian states of Kerala, Karnataka, Assam, and Tamil Nadu. The company primarily involves in highway and heavy construction, mining and quarrying, and construction and maintenance of high temperature plants, including cement and steel plants. It also offers infrastructure materials, such as rock aggregate, bricks, concrete, and other building materials, as well as provides logistical support for the transportation of infrastructure materials. In addition, the company involves in exporting iron ore to China. Its customers include various Indian government organizations and steel mills in China. The company is headquartered in Bethesda, Maryland.

IGC ~~~~~~~~ 0.6279


India Globalization Capital, Inc., through its subsidiaries, operates as an integrated infrastructure company in India and China. It engages in the execution of civil construction, structural engineering projects, and trading primarily in the Indian states of Kerala, Karnataka, Assam, and Tamil Nadu. The company primarily involves in highway and heavy construction, mining and quarrying, and construction and maintenance of high temperature plants, including cement and steel plants. It also offers infrastructure materials, such as rock aggregate, bricks, concrete, and other building materials, as well as provides logistical support for the transportation of infrastructure materials. In addition, the company involves in exporting iron ore to China. Its customers include various Indian government organizations and steel mills in China. The company is headquartered in Bethesda, Maryland.

Stock Alert ~~~~~~~~ IGC


India Globalization Capital, Inc., through its subsidiaries, operates as an integrated infrastructure company in India and China. It engages in the execution of civil construction, structural engineering projects, and trading primarily in the Indian states of Kerala, Karnataka, Assam, and Tamil Nadu. The company primarily involves in highway and heavy construction, mining and quarrying, and construction and maintenance of high temperature plants, including cement and steel plants. It also offers infrastructure materials, such as rock aggregate, bricks, concrete, and other building materials, as well as provides logistical support for the transportation of infrastructure materials. In addition, the company involves in exporting iron ore to China. Its customers include various Indian government organizations and steel mills in China. The company is headquartered in Bethesda, Maryland.

Stock Alert ~~~~~~~~ IGC


India Globalization Capital, Inc., through its subsidiaries, operates as an integrated infrastructure company in India and China. It engages in the execution of civil construction, structural engineering projects, and trading primarily in the Indian states of Kerala, Karnataka, Assam, and Tamil Nadu. The company primarily involves in highway and heavy construction, mining and quarrying, and construction and maintenance of high temperature plants, including cement and steel plants. It also offers infrastructure materials, such as rock aggregate, bricks, concrete, and other building materials, as well as provides logistical support for the transportation of infrastructure materials. In addition, the company involves in exporting iron ore to China. Its customers include various Indian government organizations and steel mills in China. The company is headquartered in Bethesda, Maryland.

RE: FOFU


Any major good news will move it to da moon, it is on my watch list. Thanks.

Happy Trading
TheChosenOne

RE: NBRI


I do believe NBRI will move to a new high after the consolidation is done. I will keep watching for the place to entry. Thanks a lot.

Best Regards
TheChosenOne

RE: ESLR

I watched ESLR shortly after market open and noticed it start making a move but I thought it will stop at $1.50 and I underestimate it's move. I was busy at work today and I decided not to open a new trade since I won't have much time to check on the stock market. Thanks for your kind notice on ESLR.


Best Regards
TheChosenOne

GIGM ~~~~~~~~ HOD $1.35

GIGM ~~~~~~~~ HOD $1.35

GIGM ~~~~~~~~ Swing Time !

GIGM is moving now

GIGM ~~~~~~~~ $1.34

GIGM ~~~~~~~~ $1.34

GIGM ~~~~~~~~ $1.22


Gigamedia Limited provides gaming software and services to the online gaming industry, as well as operates online games in the People?s Republic of China, Taiwan, Hong Kong, and Macau. It develops and licenses online poker and casino gaming software solutions and application services primarily for continental European markets. The company offers online gaming software, online gaming management tools, and application and consulting services. It also operates play-for-fun games online. The company provides a portfolio of online games, including MahJong, a traditional Chinese tile game; MMORPG, an Internet-based computer game; advanced casual games; and card, chance-based, and simple casual games. The company offers its products and services to online poker and casino markets. It has strategic alliance with Access China Holding Limited, Numen Soft Co. Ltd., and Gorilla Banana Entertainment Corp. GigaMedia Limited was founded in 1997 and is headquartered in Taipei, Taiwan.

GIGM ~~~~~~~~ 1.22


Gigamedia Limited provides gaming software and services to the online gaming industry, as well as operates online games in the People?s Republic of China, Taiwan, Hong Kong, and Macau. It develops and licenses online poker and casino gaming software solutions and application services primarily for continental European markets. The company offers online gaming software, online gaming management tools, and application and consulting services. It also operates play-for-fun games online. The company provides a portfolio of online games, including MahJong, a traditional Chinese tile game; MMORPG, an Internet-based computer game; advanced casual games; and card, chance-based, and simple casual games. The company offers its products and services to online poker and casino markets. It has strategic alliance with Access China Holding Limited, Numen Soft Co. Ltd., and Gorilla Banana Entertainment Corp. GigaMedia Limited was founded in 1997 and is headquartered in Taipei, Taiwan.

Stock To Watch ~~~~~~~~ GIGM


Gigamedia Limited provides gaming software and services to the online gaming industry, as well as operates online games in the People?s Republic of China, Taiwan, Hong Kong, and Macau. It develops and licenses online poker and casino gaming software solutions and application services primarily for continental European markets. The company offers online gaming software, online gaming management tools, and application and consulting services. It also operates play-for-fun games online. The company provides a portfolio of online games, including MahJong, a traditional Chinese tile game; MMORPG, an Internet-based computer game; advanced casual games; and card, chance-based, and simple casual games. The company offers its products and services to online poker and casino markets. It has strategic alliance with Access China Holding Limited, Numen Soft Co. Ltd., and Gorilla Banana Entertainment Corp. GigaMedia Limited was founded in 1997 and is headquartered in Taipei, Taiwan.

Stock To Watch ~~~~~~~~ GIGM


Gigamedia Limited provides gaming software and services to the online gaming industry, as well as operates online games in the People?s Republic of China, Taiwan, Hong Kong, and Macau. It develops and licenses online poker and casino gaming software solutions and application services primarily for continental European markets. The company offers online gaming software, online gaming management tools, and application and consulting services. It also operates play-for-fun games online. The company provides a portfolio of online games, including MahJong, a traditional Chinese tile game; MMORPG, an Internet-based computer game; advanced casual games; and card, chance-based, and simple casual games. The company offers its products and services to online poker and casino markets. It has strategic alliance with Access China Holding Limited, Numen Soft Co. Ltd., and Gorilla Banana Entertainment Corp. GigaMedia Limited was founded in 1997 and is headquartered in Taipei, Taiwan.

BIOD ~~~~~~~~ $2.58

BIOD ~~~~~~~~ $2.56

BIOD ~~~~~~~~ $2.53


Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules. Its product candidates include VIAject, an injectable formulation of recombinant human insulin, which has completed two pivotal Phase III clinical trials for the treatment of Type 1 and Type 2 diabetes; and VIAtab, a sublingual tablet formulation of insulin, which has completed Phase I clinical trial for Type 1 diabetes. The company was founded in 2003 and is headquartered in Danbury, Connecticut.

BIOD ~~~~~~~~ $2.53


Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules. Its product candidates include VIAject, an injectable formulation of recombinant human insulin, which has completed two pivotal Phase III clinical trials for the treatment of Type 1 and Type 2 diabetes; and VIAtab, a sublingual tablet formulation of insulin, which has completed Phase I clinical trial for Type 1 diabetes. The company was founded in 2003 and is headquartered in Danbury, Connecticut.

Stock To Watch ~~~~~~~~ BIOD


Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules. Its product candidates include VIAject, an injectable formulation of recombinant human insulin, which has completed two pivotal Phase III clinical trials for the treatment of Type 1 and Type 2 diabetes; and VIAtab, a sublingual tablet formulation of insulin, which has completed Phase I clinical trial for Type 1 diabetes. The company was founded in 2003 and is headquartered in Danbury, Connecticut.

Stock To Watch ~~~~~~~~ BIOD


Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules. Its product candidates include VIAject, an injectable formulation of recombinant human insulin, which has completed two pivotal Phase III clinical trials for the treatment of Type 1 and Type 2 diabetes; and VIAtab, a sublingual tablet formulation of insulin, which has completed Phase I clinical trial for Type 1 diabetes. The company was founded in 2003 and is headquartered in Danbury, Connecticut.

BIOD ~~~~~~~~ $2.43

BIOD ~~~~~~~~ $2.43

BIOD ~~~~~~~~ $2.43

BIOD ~~~~~~~~ $2.43

Stock To Watch ~~~~~~~~ GIGM


Gigamedia Limited provides gaming software and services to the online gaming industry, as well as operates online games in the People?s Republic of China, Taiwan, Hong Kong, and Macau. It develops and licenses online poker and casino gaming software solutions and application services primarily for continental European markets. The company offers online gaming software, online gaming management tools, and application and consulting services. It also operates play-for-fun games online. The company provides a portfolio of online games, including MahJong, a traditional Chinese tile game; MMORPG, an Internet-based computer game; advanced casual games; and card, chance-based, and simple casual games. The company offers its products and services to online poker and casino markets. It has strategic alliance with Access China Holding Limited, Numen Soft Co. Ltd., and Gorilla Banana Entertainment Corp. GigaMedia Limited was founded in 1997 and is headquartered in Taipei, Taiwan.

Stock To Watch ~~~~~~~~ GIGM


Gigamedia Limited provides gaming software and services to the online gaming industry, as well as operates online games in the People?s Republic of China, Taiwan, Hong Kong, and Macau. It develops and licenses online poker and casino gaming software solutions and application services primarily for continental European markets. The company offers online gaming software, online gaming management tools, and application and consulting services. It also operates play-for-fun games online. The company provides a portfolio of online games, including MahJong, a traditional Chinese tile game; MMORPG, an Internet-based computer game; advanced casual games; and card, chance-based, and simple casual games. The company offers its products and services to online poker and casino markets. It has strategic alliance with Access China Holding Limited, Numen Soft Co. Ltd., and Gorilla Banana Entertainment Corp. GigaMedia Limited was founded in 1997 and is headquartered in Taipei, Taiwan.

BIOD ~~~~~~~~ $2.31


Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules. Its product candidates include VIAject, an injectable formulation of recombinant human insulin, which has completed two pivotal Phase III clinical trials for the treatment of Type 1 and Type 2 diabetes; and VIAtab, a sublingual tablet formulation of insulin, which has completed Phase I clinical trial for Type 1 diabetes. The company was founded in 2003 and is headquartered in Danbury, Connecticut.

BIOD ~~~~~~~~ $2.31


Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules. Its product candidates include VIAject, an injectable formulation of recombinant human insulin, which has completed two pivotal Phase III clinical trials for the treatment of Type 1 and Type 2 diabetes; and VIAtab, a sublingual tablet formulation of insulin, which has completed Phase I clinical trial for Type 1 diabetes. The company was founded in 2003 and is headquartered in Danbury, Connecticut.

Stock To Watch ~~~~~~~~ BIOD @ $3.33


Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules. Its product candidates include VIAject, an injectable formulation of recombinant human insulin, which has completed two pivotal Phase III clinical trials for the treatment of Type 1 and Type 2 diabetes; and VIAtab, a sublingual tablet formulation of insulin, which has completed Phase I clinical trial for Type 1 diabetes. The company was founded in 2003 and is headquartered in Danbury, Connecticut.

Stock To Watch ~~~~~~~~ BIOD @ $3.33


Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules. Its product candidates include VIAject, an injectable formulation of recombinant human insulin, which has completed two pivotal Phase III clinical trials for the treatment of Type 1 and Type 2 diabetes; and VIAtab, a sublingual tablet formulation of insulin, which has completed Phase I clinical trial for Type 1 diabetes. The company was founded in 2003 and is headquartered in Danbury, Connecticut.

Thanks ~~~ BIOD chart looks promising, JMHO

BIOD ~~~~~~~~ $2.27

BIOD ~~~~~~~~ $2.25


Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules. Its product candidates include VIAject, an injectable formulation of recombinant human insulin, which has completed two pivotal Phase III clinical trials for the treatment of Type 1 and Type 2 diabetes; and VIAtab, a sublingual tablet formulation of insulin, which has completed Phase I clinical trial for Type 1 diabetes. The company was founded in 2003 and is headquartered in Danbury, Connecticut.

BIOD ~~~~~~~~ $2.25


Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules. Its product candidates include VIAject, an injectable formulation of recombinant human insulin, which has completed two pivotal Phase III clinical trials for the treatment of Type 1 and Type 2 diabetes; and VIAtab, a sublingual tablet formulation of insulin, which has completed Phase I clinical trial for Type 1 diabetes. The company was founded in 2003 and is headquartered in Danbury, Connecticut.

Stock Alert ~~~~~~~~ BIOD


Biodel Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes. The company develops its product candidates by utilizing its proprietary VIAdel technology that allows to study the interaction between peptide hormones and small molecules. Its product candidates include VIAject, an injectable formulation of recombinant human insulin, which has completed two pivotal Phase III clinical trials for the treatment of Type 1 and Type 2 diabetes; and VIAtab, a sublingual tablet formulation of insulin, which has completed Phase I clinical trial for Type 1 diabetes. The company was founded in 2003 and is headquartered in Danbury, Connecticut.